OR51I1 Antibody

What is OR51I1 and what cellular functions does it perform?

OR51I1 (olfactory receptor family 51 subfamily I member 1) is a G-protein coupled receptor with a canonical length of 314 amino acid residues and molecular weight of approximately 35.5 kDa. It primarily localizes to the cell membrane and functions as part of the G-protein coupled receptor 1 protein family . Its primary physiological role involves the sensory perception of smell, though research continues to uncover potential non-olfactory functions in various tissues. The protein is also known by several synonyms including HOR5'Beta11, odorant receptor HOR5'beta11, olfactory receptor OR11-39, and olfactory receptor 51I1 .

What are the recommended applications for OR51I1 antibodies in research?

The most common and validated applications for OR51I1 antibodies include Western Blot (WB), Enzyme-Linked Immunosorbent Assay (ELISA), and Immunofluorescence (IF)/Immunocytochemistry (ICC) . When selecting an antibody, researchers should consider the specific experimental requirements:

The choice of application should be dictated by the specific research question, with Western Blot providing information on protein size and expression levels, ELISA offering quantitative analysis, and immunofluorescence revealing subcellular localization patterns.

How should researchers validate OR51I1 antibody specificity?

Antibody validation is critical for ensuring experimental reliability. A comprehensive validation approach should include:

• Positive controls using tissues or cells known to express OR51I1

• Negative controls using tissues or cells without OR51I1 expression

• Peptide blocking experiments to confirm epitope-specific binding

• Comparison of results across multiple antibodies targeting different epitopes

• Correlation with mRNA expression data when possible

Researchers should be particularly cautious with commercial anti-GPCR antibodies, as studies of related olfactory receptors have noted "notorious lack of activity" with some commercial antibodies . When publishing results, detailed antibody validation methods should be included in materials and methods sections.

What species reactivity should be considered when selecting an OR51I1 antibody?

OR51I1 antibodies exhibit variable cross-reactivity across species. Available commercial antibodies demonstrate reactivity with human samples most consistently, while some also react with mouse and monkey samples . When planning cross-species studies, it is essential to:

• Verify the antibody's documented species reactivity

• Consider sequence homology between species variants of OR51I1

• Perform preliminary validation in each species of interest

• Use species-specific positive controls during optimization

This consideration is particularly important when designing comparative studies across multiple model organisms.

How can OR51I1 trafficking and membrane localization be effectively analyzed?

Analysis of OR51I1 membrane trafficking represents a critical aspect of research into olfactory receptor function. Based on studies of related olfactory receptors, researchers should consider:

• Using N-terminal epitope tags (such as FLAG) to facilitate detection without disrupting function

• Employing cell surface biotinylation assays to quantify membrane-localized protein

• Implementing fluorescence microscopy with non-permeabilized cells to specifically detect surface-expressed receptors

• Comparing total protein expression versus membrane localization using complementary techniques

Recent research on the related receptor OR51E1 demonstrates that replacing the N-terminus can significantly impact trafficking to the plasma membrane . Similar approaches may be valuable for investigating OR51I1 trafficking mechanisms.

What signaling pathways are activated by OR51I1 and how can they be measured?

As a G-protein coupled receptor, OR51I1 likely signals through canonical G-protein pathways. Based on research with related receptors:

• cAMP signaling can be measured through:

  • Indirect detection of PKA-mediated phosphorylation using phospho-specific antibodies

  • Direct measurement using fluorescence-based real-time cAMP biosensors

  • ELISA-based cAMP quantification assays

• Calcium signaling analysis using:

  • Calcium-sensitive fluorescent dyes

  • Genetically encoded calcium indicators

  • Electrophysiology techniques in specialized cellular contexts

Researchers should note that related olfactory receptors can activate differential signaling pathways depending on cellular context and ligand binding .

What are the emerging roles of OR51I1 in cancer research and potential therapeutic applications?

Based on research with related olfactory receptors OR51E1, OR51E2, and OR51J1, there is growing interest in the potential roles of OR51I1 in cancer biology:

• Expression analysis techniques:

  • Quantitative Real-Time PCR (qRT-PCR) to measure mRNA expression levels across normal and cancer tissues

  • Immunohistochemistry (IHC) to evaluate protein expression in different cellular compartments within tumor microenvironments

  • Correlation with clinical parameters to establish prognostic significance

• Functional analysis approaches:

  • Overexpression systems using inducible promoters to control expression levels

  • siRNA or CRISPR-based knockdown/knockout to assess loss-of-function effects

  • Cell proliferation, migration, and invasion assays to determine phenotypic consequences

Research on the related receptor OR51J1 has demonstrated significant upregulation in multiple cancer types, including breast cancer (2.91-fold higher expression in tumors versus normal tissues) . Similar investigations of OR51I1 may reveal previously uncharacterized roles in cancer development or progression.

How can researchers overcome technical challenges in OR51I1 functional characterization?

Functional characterization of olfactory receptors presents several technical challenges:

• Low expression levels and poor trafficking to plasma membranes:

  • Use of trafficking-enhancing sequences or chaperones

  • Creation of chimeric constructs with better-expressing receptors

  • Optimization of expression systems using inducible promoters

• Potential cytotoxicity upon overexpression:

  • Implementation of tetracycline-inducible expression systems to control expression levels

  • Careful monitoring of cell viability following transfection

  • Time-course analyses to identify optimal expression windows

• Identification of ligands and functional assays:

  • Screening of structurally related compounds to identify activators

  • Utilization of multiple readout systems to confirm functional responses

  • Comparison with related, better-characterized receptors as positive controls

What are the optimal tissue preparation protocols for OR51I1 immunohistochemistry?

Effective immunohistochemical detection of OR51I1 requires careful optimization of tissue preparation and staining protocols:

• Fixation considerations:

  • 10% neutral-buffered formalin for 24-48 hours

  • Paraffin embedding using standard protocols

  • Section thickness of 4-5 μm for optimal staining

• Antigen retrieval methods:

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0) or EDTA buffer (pH 9.0)

  • Pressure cooker-based retrieval for 15-20 minutes

  • Cooling to room temperature before antibody application

• Antibody incubation parameters:

  • Primary antibody dilutions should be optimized (typically 1:50-1:200)

  • Overnight incubation at 4°C often provides optimal signal-to-noise ratio

  • Appropriate negative controls should always be included

The assessment of staining should follow semi-quantitative methods, categorizing expression as negative, weak (1+), moderate (2+), or strong (3+) to enable statistical comparisons across sample cohorts .

How should researchers analyze OR51I1 expression data in complex tissue samples?

Analysis of OR51I1 expression in heterogeneous tissue samples requires sophisticated approaches:

• Cell type-specific analysis:

  • Evaluation of expression in different cellular compartments (e.g., epithelial cells, fibroblasts, lymphocytes)

  • Scoring of expression intensity in each compartment

  • Creation of composite scores using principal component analysis

• Correlation with clinical parameters:

  • Statistical methods including Pearson's chi-squared test or Fisher's exact test

  • Analysis of associations with disease markers (e.g., hormone receptor status in cancer)

  • Survival analysis to determine prognostic significance

• Digital pathology approaches:

  • Implementation of automated image analysis for objective quantification

  • Machine learning algorithms for pattern recognition

  • Multiplex immunofluorescence to correlate with other biomarkers

How does OR51I1 compare structurally and functionally to OR51E1 and OR51E2?

Understanding the structural and functional relationships between OR51I1 and other olfactory receptors provides valuable research context:

Researchers should consider these relationships when designing experiments and interpreting results, particularly when comparing across the OR51 family.

What experimental systems are most suitable for studying OR51I1 signaling and function?

Based on research with related olfactory receptors, several experimental systems may be suitable for OR51I1 studies:

• Cell line selection considerations:

  • Prostate cancer cell lines (e.g., LNCaP) have been effective for studying related receptors

  • HEK293 cells provide a common heterologous expression system

  • Primary cells from tissues with endogenous expression may provide physiological relevance

• Expression system optimization:

  • Inducible expression systems to control protein levels and mitigate potential toxicity

  • Addition of trafficking enhancement sequences to improve membrane localization

  • Inclusion of epitope tags (e.g., FLAG) to facilitate detection

• Functional readout systems:

  • cAMP assays using biosensors or ELISA-based methods

  • Calcium imaging with fluorescent indicators

  • Phosphorylation of downstream signaling proteins (e.g., ERK1/2)

Researchers should carefully select systems that align with their specific research questions, considering both the advantages and limitations of each approach.

What are the potential research applications of OR51I1 as a cancer biomarker?

Based on findings with related olfactory receptors, OR51I1 may have potential as a cancer biomarker:

• Expression profiling approaches:

  • Comprehensive analysis across multiple cancer types

  • Correlation with established biomarkers and clinical outcomes

  • Development of standardized detection methods

• Functional significance investigation:

  • Impact on cancer cell proliferation, similar to effects observed with OR51E1/OR51E2

  • Potential role in cell death pathways

  • Influence on tumor microenvironment

The related receptor OR51J1 has demonstrated increased expression in more than 20 cancer types and showed 2.91-fold higher expression in breast tumors compared to normal tissues . Similar comprehensive profiling of OR51I1 could reveal valuable biomarker applications.

How can CRISPR-Cas9 gene editing be applied to OR51I1 research?

CRISPR-Cas9 technology offers powerful approaches for OR51I1 research:

• Functional genomics applications:

  • Generation of knockout cell lines to study loss-of-function effects

  • Creation of knock-in models with fluorescent tags for live-cell imaging

  • Introduction of specific mutations to study structure-function relationships

• Technical considerations:

  • Design of guide RNAs specific to OR51I1 to minimize off-target effects

  • Screening strategies to identify successful edited clones

  • Validation approaches to confirm functional consequences

• Translation to animal models:

  • Creation of knockout or knock-in mouse models

  • Investigation of physiological roles in development and disease

  • Comparative analysis with related olfactory receptors

This technology can help overcome many of the traditional challenges associated with olfactory receptor research by enabling precise genetic manipulation.